44 Wealth Management’s CVS Health CVS Stock Holding History

44 Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Sell	32,817 -306	-0.9%	-$23.6K	0.82%	35
2025 Q4	$2.63M	Sell	33,123 -3,275	-9%	-$258K	0.88%	29
2025 Q3	$2.74M	Buy	36,398 +36	+0.1%	+$2.47K	0.93%	23
2025 Q2	$2.51M	Sell	36,362 -697	-2%	-$45.7K	0.89%	29
2025 Q1	$2.51M	Buy	37,059 +2,716	+8%	+$163K	0.94%	28
2024 Q4	$1.54M	Sell	34,343 -9,645	-22%	-$541K	0.59%	51
2024 Q3	$2.5M	Buy	+43,988	New	+$2.57M	0.88%	31
2023 Q2	$269K	Sell	3,885 -3,264	-46%	-$232K	0.09%	145
2023 Q1	$531K	Sell	7,149 -826	-10%	-$69.3K	0.18%	104
2022 Q4	$743K	Sell	7,975 -81	-1%	-$7.82K	0.26%	88
2022 Q3	$768K	Sell	8,056 -4,008	-33%	-$397K	0.32%	81
2022 Q2	$1.12M	Buy	12,064 +122	+1%	+$11.9K	0.43%	64
2022 Q1	$1.21M	Sell	11,942 -2,597	-18%	-$273K	0.44%	61
2021 Q4	$1.5M	Buy	14,539 +1,088	+8%	+$101K	0.52%	50
2021 Q3	$1.14M	Sell	13,451 -221	-2%	-$18.5K	0.44%	59
2021 Q2	$1.14M	Buy	13,672 +319	+2%	+$26.1K	0.44%	57
2021 Q1	$1M	Sell	13,353 -2,356	-15%	-$172K	0.42%	57
2020 Q4	$1.07M	Buy	+15,709	New	+$1.02M	0.49%	49

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

44 Wealth Management's CVS Position: Q1 2026 in Review

44 Wealth Management reduced its CVS Health (CVS) stake by 0.92% in Q1 2026, selling an estimated $23.6K and leaving 32,817 shares worth $2.36M. The position accounts for 0.82% of the portfolio, ranked #35.

44 Wealth Management first reported a position in CVS in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.74M in Q3 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

44 Wealth Management held 32,817 shares of CVS Health worth $2.36M as of Q1 2026.
44 Wealth Management sold 306 CVS Health shares in Q1 2026, an estimated $23.6K.
CVS Health made up 0.82% of 44 Wealth Management's portfolio in Q1 2026, its #35 holding.
44 Wealth Management first reported a position in CVS Health in Q4 2020 and has held it in 18 quarters since.
44 Wealth Management's CVS Health position peaked at $2.74M in Q3 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.